Advertisement

The changing role of surgery in the diagnosis and treatment of cancer

  • David Mintzer
    Correspondence
    Requests for reprints should be addressed to David Mintzer, MD, 822 Pine Street, Suite 2A, Philadelphia, Pennsylvania 19107
    Affiliations
    Department of Medicine, Pennsylvania Hospital, Philadelphia, Pennsylvania, USA
    Search for articles by this author

      Abstract

      Many changes have occurred in the surgical treatment of the cancer patient. For many tumors, surgery has been modified or eliminated. These changes are due to the realization that, for some cancers, more extensive surgical procedures are not more beneficial, to improvements in radiation therapy and chemotherapy, to the availability of better noninvasive or less invasive diagnostic and therapeutic techniques, and to improved surgical equipment (such as videoscopic surgery).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gazelle G.C
        • Haaga J.R
        Imaging-guided percutaneous abdominal biopsy.
        Oncology. 1991; 5: 27-38
        • Fisher B
        • Redmond C
        • Fisher E
        Ten year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.
        NEJM. 1985; 312: 674-681
        • Fisher B
        • Redmond C
        • Poisson R
        • et al.
        Eight year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer.
        NEJM. 1989; 320: 822-828
        • Veronesi U
        • Saccozzi R
        • Del Becchio M
        • et al.
        Comparing radical mastectomy with quadrantectomy, axillary dissection and radiotherapy in patients with small cancers of the breast.
        NEJM. 1981; 305: 6-11
      1. Harris JR, Lippman ME, Veronesi U, et al. Breast cancer. NEJM 1992:319–328,390–398,473–480.

        • Early Breast Cancer Trialists Collaborative Group
        Effects of radiotherapy and surgery in early breast cancer—an overview of the randomized trials.
        NEJM. 1995; 333: 1444-1455
        • Fisher B
        • Mamounas E.P
        Preoperative chemotherapy.
        J Clin Oncol. 1995; 13: 537-540
        • Recht A
        • Houlihan M.J
        Axillary lymph nodes and breast cancer.
        Cancer. 1995; 76: 1491-1512
        • Krag D.N
        • Weaver D.L
        • Alex J.C
        • Fairbank J.R
        Surgical resection and radiolocalization of sentinel lymph node in breast cancer using a gamma probe.
        Surg Onc. 1993; 2: 335-340
        • Morrow M
        • Schnitt S
        • Harris J
        Ductal carcinoma in situ.
        in: Harris J.R Lippman M.E Morrow M Hellman S Diseases of the Breast. Lippincott-Raven, 1995: 353-373
        • Fisher B
        • Constantino J
        • Redmond C
        • et al.
        Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer.
        NEJM. 1993; 328: 1581-1586
        • Morrow M
        • Schnitt S
        • Harris J
        Ductal carcinoma in situ.
        in: Harris J.R Lippman M.E Morrow M Hellman S Diseases of the Breast. Lippincott-Raven, 1995: 369-373
        • Pettine S
        • Place R
        • Babu S
        • Williard W
        • Kim D
        • Carter P
        Stereotactic breast biopsy is accurate, minimally invasive and cost effective.
        Am J Surg. 1996; 171: 474-476
        • Wallace J.E
        • Sayler C
        • McDowell N.G
        • Moseley H.S
        The role of stereotactic biopsy in assessment of nonpalpable breast lesions.
        Am J Surg. 1996; 171: 471-473
        • Hernandez L.E
        • Connelly P.J
        • Strickler S.A
        • Akers M.M
        • Dunn M.M
        Are sterotaxic breast biopsies adequate?.
        Surgery. 1994; 116: 610-614
        • Pettine S
        • Place R
        • Babu S
        • Williard W
        • Kim D
        • Carter P
        Stereotactic breast biopsy is accurate, minimally invasive and cost effective.
        Am J Surg. 1996; 171: 474-476
        • Wallace J.E
        • Sayler C
        • McDowell N.G
        • Moseley H.S
        The role of stereotactic biopsy in assessment of nonpalpable breast lesions.
        Am J Surg. 1996; 17: 471-473
        • Hernandez L.E
        • Connelly P.J
        • Strickler S.A
        • Akers M.M
        • Dunn M.M
        Are stereotaxic breast biopsies adequate?.
        Surgery. 1994; 116: 610-614
        • Mitnick J.S
        • Vazquez M.F
        • Pressman P.I
        • Harris M.N
        • Roses D.F
        Stereotactic fine-needle aspiration biopsy for the evaluation of nonpalpable breast lesions; report of an experience based on 2,988 cases.
        Ann Surg Oncol. 1996; 3: 185-191
        • Ingle J.M
        • Krook J.E
        • Green S.J
        • et al.
        Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer.
        J Clin Oncol. 1986; 4: 178-185
        • Buchanan R.B
        • Blamey R.W
        • Durrant K.R
        • et al.
        A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer.
        J Clin Oncol. 1986; 4: 1326-1330
        • Harvey H.A
        • Lipton A
        • Max D.T
        Medical castration produced by the GnRH analogue leuprolide to treat metastatic breast cancer.
        J Clin Oncol. 1985; 3: 1068-1072
        • Santen R.J
        • Worgul T.J
        • Samojlik E
        A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer.
        NEJM. 1981; 305: 545-551
        • Pappa V.I
        • Hussain H.K
        • Reznek R.H
        • et al.
        Role of image-guided core-needle biopsy in the management of patients with lymphoma.
        J Clin Oncol. 1996; 14: 2427-2430
        • Ben-Yehuda D
        • Polliack A
        • Okon E
        • et al.
        Image-guided core-needle biopsy in malignant lymphoma.
        J Clin Oncol. 1996; 14: 2431-2434
      2. Sklar J, Longtine J. The clinical significance of antigen receptor gene rearrangements in lymphoid neoplasia. Cancer 1992;70(suppl):1710–1708.

        • Miller T.P
        • Jones S.E
        Initial chemotherapy for clinically localized lymphomas of unfavorable histology.
        Blood. 1983; 62: 413-418
        • Connors J.M
        • Klimo P
        • Rairey R.N
        • et al.
        Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma.
        Ann Intern Med. 1987; 107: 25-30
        • Mauch P
        Controversies in the management of early stage Hodgkin’s disease.
        Blood. 1994; 83: 318-329
        • Spinelli P
        • Beretta G
        • Bajetta E
        • et al.
        Laparoscopy and lapartomomy combined with bone marrow biopsy in staging Hodgkin’s disease.
        BMJ. 1975; 4: 554-556
        • Leflvor A.T
        • Flowers J.L
        • Heyman M.R
        Laparscopic staging of Hodgkins disease.
        Surg Oncol. 1993; 2: 217-220
        • Department of Veterans Affairs Laryngeal Cancer Study Group
        Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.
        NEJM. 1991; 325: 1685-1690
        • Pfister D.G
        • Strong E
        • Harrison L
        • et al.
        Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer.
        J Clin Oncol. 1991; 9: 850-859
        • Lefebvre J.-L
        • Chevalier D
        • Luboinski B
        • Kirkpatrick A
        • Collette L
        • Sahmoud T
        Larynx preservation in pyriform sinus cancer.
        J Nat Can Inst. 1996; 88: 890-899
        • Byers R.M
        Modified neck dissection.
        Am J Surg. 1980; 150: 414-421
        • Medina J.E
        • Byers R.M
        Supraomohyoid neck dissection.
        Head Neck. 1989; 11: 111-122
        • Golomb H.M
        • Catovsky D
        • Golde D.W
        Hairy cell leukemia.
        Ann Intern Med. 1978; 89: 677-683
        • Golomb H.M
        • Vardiman J.W
        Response to splenectomy in 65 patients with hairy cell leukemia.
        Blood. 1983; 61: 349-352
        • Quesada J.R
        • Hersh E.M
        • Manning J
        • et al.
        Treatment of hairy cell leukemia with recombinant alpha interferon.
        Blood. 1985; 68: 493-497
        • Piro L.D
        • Carrera C.J
        • Carons D.A
        • Beutler E
        Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
        NEJM. 1990; 322: 1117-1121
        • Estey E.H
        • Kurzrock R
        • Kantarjian H.M
        • et al.
        Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA).
        Blood. 1992; 79: 882-887
        • Nigro N.D
        • Vaitkevicius V.K
        • Considine Jr, B
        Combined therapy for cancer of the anal canal.
        Dis Colon Rectum. 1974; 17: 354-356
        • Leichman L
        • Nigro N
        • Vaitkeviceus V.K
        • et al.
        Cancer of the anal canal.
        Am J Med. 1985; 78: 211-216
        • Enker W.E
        • Heilweil M
        • Janov A.J
        • et al.
        Improved survival in epidermoid carcinoma of the anus in association with pre-operative multi-disciplinary therapy.
        Arch Surg. 1986; 121: 1386-1390
        • Cummings B.J
        • Keane T.J
        • O’Sullivan V
        • Wong C.S
        • Catton C.N
        Epidermoid anal cancer.
        Int J Radiat Oncol Biol Phys. 1991; 21: 1115-1125
        • Graham R.A
        • Garnsey L
        • Jessup J.M
        Local excision of rectal carcinoma.
        Am J Surg. 1990; 106: 306-312
        • Jessup J.M
        • Bleday R
        • Busse P
        • et al.
        Conservative management of rectal carcinoma.
        Semin Surg Oncol. 1993; 9: 39-45
        • Veronesi U
        • Cascinelli N
        • Adamus J
        • et al.
        Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm.
        NEJM. 1988; 318: 1159-1162
        • Balch C.M
        • Urist M.M
        • Karakousis C.P
        • et al.
        Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm): results of a multi-institutional randomized surgical trial.
        Ann Surg. 1993; 218: 262-267
        • Veronesi U
        • Adams J
        • Bandiera D.C
        • et al.
        Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities.
        Cancer. 1982; 49: 2420-2430
        • Sim F.H
        • Taylor W.F
        • Prichard D.J
        • et al.
        Lymphadenectomy in the management of stage I malignant melanoma.
        Mayo Clinic Proc. 1986; 61: 697-705
        • Balch C.M
        • Milton G.W
        • Cascinelli N
        • Milton G.W
        • Sim F.H
        Elective node dissection: pros and cons.
        in: Balch C.M Houghton A.N Milton G.W Sober A Soong S-j Cutaneous Melanoma. 2nd ed. JF Lippincott, Philadelphia1992: 345
        • Balch C.M
        • Soong S
        • Bartolucci
        • et al.
        Efficacy of an elective regional lymph node dissection of 1 to 4 mm. thick melanomas for patients 60 years of age and younger.
        Ann Surg. 1996; 224: 255-266
        • Morton D.L
        • Wen D.R
        • Wong J.H
        • et al.
        Technical details of intraoperative lymphatic mapping for early stage melanoma.
        Arch Surg. 1992; 127: 392-399
        • Ross M.I
        • Reintgen D.L
        • Balch C.M
        Selective lymphadenectomy.
        Semin Surg Oncol. 1993; 9: 219-223
        • Kirkwood J.M
        • Strawderman M.H
        • Ernstoff M.S
        • et al.
        Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma.
        J Clin Oncol. 1996; 14: 7-17
        • Shields J.A
        • Shields C.S
        Current management of posterior uveal melanoma.
        Mayo Clin Proc. 1993; 68: 1196-1200
        • Morton R.A
        • Steiner M.S
        • Walsh P.C
        Cancer control following anatomical radical prostatectomy.
        J Urol. 1991; 145: 1197-1200
        • Kavoussi L.R
        • Sosa E
        • Chankhoke P
        • et al.
        Complications of laparoscopic pelvic lymph node dissection.
        J Urol. 1993; 149: 322-325
        • Bahn D.K
        • Lee F
        • Solomon M.H
        • Gontina H
        • Klionsky D.L
        • Lee Jr, F.T
        Prostate cancer: ultrasound-guided percutaneous cryoablation. Work in progress.
        Radiology. 1995; 194: 551-556
        • Onik G.M
        • Cohen J.K
        • Reyes G.H
        • Rubinsky B
        • Chang Z
        • Baust J
        Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate.
        Cancer. 1993; 72: 1291-1299
        • D’Amico A.V
        • Coleman N.C
        Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer.
        J Clin Oncol. 1996; 14: 304-315
        • Catalona W.J
        Drug therapy.
        NEJM. 1994; 331: 996-1004
        • Conn P.M
        • Crowley Jr, W.F
        Gonadotropin-releasing hormone and its analogues.
        NEJM. 1991; 324: 93-103
        • Parmar H
        • Phillips R.H
        • Lightman S.L
        • Edwards L
        • Allen L
        • Schally A.V
        Randomised controlled study of orchiedectomy vs. long-acting D-Trp-6-LHRH microcapsules in advanced prostatic carcinoma.
        Lancet. 1985; 2: 1201-1205
        • Tester W
        • Porter A
        • Asbell S
        • et al.
        Combined modality program with possible organ preservation for invasive bladder carcinoma.
        Int J Radiat Oncol Biol Phys. 1993; 25: 783-790
        • Tester W
        • Caplan R
        • Heane J
        • et al.
        Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer.
        J Clin Oncol. 1996; 14: 119-126
        • Kaufman D.S
        • Shipley W.U
        • Griffin P.P
        • Henely N.M
        • Althausen A.F
        • Efird U
        Selective bladder preservation by combination treatment of invasive bladder cancer.
        NEJM. 1993; 329: 1377-1382
        • Rowland R.G
        • Mitchell M.E
        • Bihrle R
        • et al.
        Indiana continent urinary reservoir.
        J Urol. 1987; 137: 1136-1139
        • Lowe B.A
        Surveillance versus nerve-sparing retroperitoneal lymphadenectomy in stage I nonseminomatous germ-cell tumors.
        Urol Clin N Am. 1993; 20: 75-83
        • Johnson D.E
        • Lo R.K
        • von Eschenbach A.C
        • et al.
        Surveillance alone for patients with clinical stage I nonseminomatous germ cell tumors of the testis.
        J Urol. 1984; 131: 491-493
        • Pizzocaro G
        • Zanoni F
        • Milani A
        • et al.
        Orchiectomy alone in clinical stage I nonseminomatous testis cancer; a critical appraisal.
        J Clin Oncol. 1986; 4: 35-40
        • Richie J.P
        Clinical stage I testicular cancer.
        J Urol. 1990; 144: 1160-1163
        • Logothetis C.J
        • Swanson D.A
        • Dexeus F
        • et al.
        Primary chemotherapy for clinical stage II nonseminamatous germ cell tumors of the testis.
        J Clin Oncol. 1987; 5: 906-911
        • Lerner S.E
        • Mann B.S
        • Blute M.L
        • Richardson R.L
        • Zincke H
        Primary chemotherapy for clinical stage II nonseminomatous germ cell testicular tumors.
        Mayo Clin Proc. 1995; 70: 821-828
        • Rosenberg S.A
        • Tepper J
        • Glatstein E
        • et al.
        The treatment of soft tissue sarcoma of the extremities.
        Ann Surg. 1982; 196: 305-314
        • Brennan M.F
        • Casper E.S
        • Harrison L.K
        • et al.
        The role of multimodality therapy in soft-tissue sarcoma.
        Ann Surg. 1991; 214: 328-338
        • Malawer M.M
        • Link M.P
        • Donaldson S.S
        Sarcomas of Bone.
        in: DeVita Jr, V.T Hellman S Rosenberg S.A Cancer Principles and Practice of Oncology. 4th ed. JB Lippincott, 1993: 1509-1566
        • Eilber F
        • Giuliano A
        • Eckardt J
        • et al.
        Adjuvant chemotherapy for osteosarcoma; a randomized prospective trial.
        J Clin Oncol. 1987; 5: 21-26
        • Soper N.J
        • Brunt L.M
        • Kerbl K
        Laparoscopic general surgery.
        NEJM. 1994; 330: 409-419
        • Greene F.L
        Larparoscopy in malignant disease.
        Surg Clin North Am. 1992; 72: 1125-1137
        • Ota D.M
        • Nelson H
        • Weeks J.C
        Controversies regarding laparoscopic colectomy for malignant diseases.
        Curr Opin Gen Surg. 1994; : 208-213
        • Johnstone P.A.S
        • Rohde D.C
        • Swartz S.E
        • Getter J.E
        • Wexner S.D
        Port site recurrences after laparoscopic and thoracoscopic procedures in malignancy.
        J Clin Oncol. 1996; 14: 1950-1956
        • Landreneau R.J
        • Mack M.J
        • Hazelrigg S.R
        • Naunheim K.S
        • Keenan R.J
        • Ferson P.F
        The role of video-assisted thoracic surgery in thoracic oncological practice.
        Canc Invest. 1995; 13: 526-539
        • Alexander III, E
        • Moriarty T.M
        • Davis R.B
        • et al.
        Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases.
        J Nat Canc Inst. 1995; 87: 34-40
        • Phillips M.H
        • Stelzer K.J
        • Griffin T.W
        • Mayberg M.R
        • Winn H.R
        Stereotactic radiosurgery.
        J Clin Oncol. 1994; 23: 1085-1099
        • Patchell R.A
        • Tibbs P.A
        • Walsh J.W
        • et al.
        A randomized trial of surgery in the treatment of single metastases to the brain.
        NEJM. 1990; 322: 494-500
        • Ponsky J.L
        • Gauderer M.W.L
        Percutaneous endoscopic gastrostomy.
        Gastrointest Endosc. 1981; 27: 9-11
        • Speer A
        • Russell R.C.G
        • Hatfield A
        • et al.
        Randomized trial of endoscopic vs. percutaneous stent insertion for malignant obstructive jaundice.
        Lancet. 1987; ii: 57-61
        • Andrews J.C
        • Marx M.J
        • Williams D.M
        • et al.
        The upper arm approach for placement of peripherally inserted central catheters for protracted venous access.
        Am J Roentgenol. 1992; 158: 427-429
        • Kyle K.S
        • Myers J.S
        Peripherally inserted central catheters.
        J Intraven Nurs. 1989; 13: 287-290
        • Dorfman G.S
        Percutaneous inferior vena cava filters.
        Radiology. 1990; 174: 987-992
        • Sanders M
        • Zuurmond W
        Safety of unilateral and bilateral percutaneous cervical cordotomy in 80 terminally ill cancer patients.
        J Clin Oncol. 1995; 13: 1509-1512
        • Ajani J.A
        • Carrasco C.H
        • Charnsangavej C
        • et al.
        Islet cell tumors metastatic to the liver.
        Ann Intern Med. 1988; 108: 340-344
        • Charnsangavej C
        Chemoembolization of liver tumors.
        Semin Invest Radiol. 1993; 10: 150-160
        • Frucht H
        • Maton P
        • Jensen R.T
        The use omeprazole in patients with Zollinger-Ellison syndrome.
        Dig Dis Sci. 1991; 36: 394-404
        • Herskovic A
        • Martz L
        • Al-Sarraf M
        • et al.
        Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus.
        NEJM. 1992; 326: 1593-1598
        • Dillman R.O
        • Seagren S.L
        • Propert K.J
        • et al.
        A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer.
        NEJM. 1990; 323: 940-945